[1]de FRANCHIS R.Expanding consensus in portal hypertension:report of the Baveno VI Consensus Workshop:stratifying risk and individualizing care for portal hypertension[J].J Hepatol,2015,63(3):743-752.
|
[2]KAMATH PS,MOOKERJEE RP.Individualized care for portal hypertension:Not quite yet[J].J Hepatol,2015,63(3):543-545.
|
[3]BURROUGHS AK,THALHEIMER U.Hepatic venous pressure gradient in 2010:optimal measurement is key[J].Hepatology,2010,51(6):1894-1896.
|
[4]LI Z,ZHANG CQ.Clinical application of hepatic venous pressure gradient[J/CD].Chin J Digest Med Imageol:Electronic Edition,2013,3(3):1-3.(in Chinese)李振,张春清.肝静脉压力梯度测定的临床应用[J/CD].中华消化病与影像杂志:电子版,2013,3(3):1-3.
|
[5]ADDLEY J,THAM TC,CASH WJ.Use of portal pressure studies in the management of variceal haemorrhage[J].World J Gastrointest Endosc,2012,4(7):281-289.
|
[6]LI ZF,JIANG A,ZHANG S.Exploration and practice of individualized treatment strategies for cirrhotic portal hypertension[J/CD].Chin J Hepatic Surg:Electronic Edition,2015,4(3):146-149.(in Chinese)李宗芳,蒋安,张澍.肝硬化门静脉高压症个体化治疗策略的探索与实践[J/CD].中华肝脏外科手术学:电子杂志,2015,4(3):146-149.
|
[7]KANG EJ,JEONG SW,JANG JY,et al.Long-term result of endoscopic Histoacryl(N-butyl-2-cyanoacrylate)injection for treatment of gastric varices[J].World J Gastroenterol,2011,17(11):1494-1500.
|
[8]SAAD WE,KHAJA MS,HIROTA S.Balloon-occluded retrograde transvenous obliteration of gastric varices:conception,evolution,and history[J].Tech Vasc Interv Radiol,2012,15(3):160-164.
|
[9]SARASWAT VA,VERMA A.Gluing gastric varices in 2012:lessons learnt over 25 years[J].Tech Vasc Interv Radiol,2012,2(1):55-69.
|
[10]WU L,LI LH,ZHANG CQ,et al.Percutaneous trans-hepatic cyanoacrylate embolization forgastricvarices[J].Chin J Dig Endosc,2009,11(11):580-583.(in Chinese)吴蕾,李兰花,张春清,等.经皮经肝胶栓塞治疗胃静脉曲张的疗效分析[J].中华消化内镜杂志,2009,11(11):580-583.
|